ArticleCureus2025
Metastatic Paraganglioma With a Fatal Outcome Following Liver Biopsy: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Paragangliomas are rare neuroendocrine tumors that may present as hormonally active or silent masses. While generally indolent, they may metastasize and lead to severe complications, particularly when biopsied or manipulated without prior diagnosis. We describe a 53-year-old woman with a history of hypertension, diabetes, and dyslipidemia, admitted for investigation of constitutional symptoms and lytic vertebral lesions. Imaging revealed liver and bone metastases, a retroperitoneal mass, and adenopathy. A liver biopsy was performed, after which she developed hemorrhagic shock due to active hepatic bleeding. Despite successful embolization, she progressed to multiorgan failure, extensive intestinal ischemia, and death. Histological analysis revealed metastatic paraganglioma. This case highlights the diagnostic and therapeutic challenges associated with occult, functionally active paraganglioma. Invasive procedures in undiagnosed neuroendocrine tumors may trigger life-threatening complications, especially in hormonally active lesions. A routine biochemical evaluation is recommended before biopsy, as early recognition of paraganglioma in retroperitoneal masses, even when asymptomatic, is essential to prevent fatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.